Advertisement

Topics

OpGen, Inc. Company Profile

23:24 EDT 20th October 2017 | BioPortfolio

OpGen® Technologies is a leading provider of genetic analysis services and systems. The company's proprietary "Optical Mapping" system (see technology) is used by academic and commercial organizations worldwide for applications including comparative genomics and genome sequence assembly/validation. Since Optical Mapping does not require sequence information it can be applied to a wide range of organisms not amenable to analysis by other genetic analysis systems. It is a particularly powerful method for detecting genome rearrangements, including the insertions, deletions, and translocations responsible for most variation in microorganisms. Optical Mapping is currently available to researchers worldwide as a fee-for-service.

Location

510 Charmany DriveSuite 151
Madison
Wisconsin
53719
United States of America

Contact

Phone: 608.441.8100
Fax: 608.441.8101
Email: info@opgen.com


News Articles [22 Associated News Articles listed on BioPortfolio]

OpGen reaches supply agreement with Thermo Fisher

OpGen and Thermo Fisher Scientific have reached a supply agreement to commercialize OpGen's Acuitas Rapid Test for Pathogen I -More- 

OpGen nets $9.2mm in public offering

Infectious disease diagnostics developer OpGen Inc. netted $9.2mm through a public offering. The company sold 18.2mm units at $0.40; each unit consists of one common share and one five-year warrant to...

OpGen, Thermo Fisher Enter Global Supply Pact

Will combine Thermo’s PCR solutions with OpGen's genomic analysis to combat multidrug-resistant infections

OpGen looks to raise up to $15.6M in public offering

A previously announced public offering has been upsized by OpGen in hopes of raising up to $15.6 million, according to an ame -More- 

Public offering could bring in $10M for OpGen

A public offering of common stock and common warrants has been priced by OpGen in hopes of raising $10 million.  -More- 

Public offering brings in $10M for OpGen

A public offering of common stock and stock purchase warrants has pulled in $10 million for Gaithersburg, Md.-based OpGen.  -More- 

Opgen raises $10M follow-on

OpGen proposes $10M follow-on

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

OpGen, Inc.

OpGen® Technologies is a leading provider of genetic analysis services and systems. The company's proprietary "Optical Mapping" system (see technology) is used by academic and commercial organization...

More Information about "OpGen, Inc." on BioPortfolio

We have published hundreds of OpGen, Inc. news stories on BioPortfolio along with dozens of OpGen, Inc. Clinical Trials and PubMed Articles about OpGen, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of OpGen, Inc. Companies in our database. You can also find out about relevant OpGen, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record